nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—Nepafenac—Carbamazepine—epilepsy syndrome	0.168	0.52	CrCrCtD
Mebendazole—Nepafenac—Oxcarbazepine—epilepsy syndrome	0.155	0.48	CrCrCtD
Mebendazole—ABCB1—epilepsy syndrome	0.124	1	CbGaD
Mebendazole—CYP1A1—Propofol—epilepsy syndrome	0.0353	0.0915	CbGbCtD
Mebendazole—CYP1A1—Phenobarbital—epilepsy syndrome	0.0337	0.0875	CbGbCtD
Mebendazole—ABCB1—Levetiracetam—epilepsy syndrome	0.0287	0.0744	CbGbCtD
Mebendazole—ABCB1—Clobazam—epilepsy syndrome	0.0199	0.0516	CbGbCtD
Mebendazole—ABCB1—Lamotrigine—epilepsy syndrome	0.0191	0.0497	CbGbCtD
Mebendazole—ABCB1—Carbamazepine—epilepsy syndrome	0.0165	0.0427	CbGbCtD
Mebendazole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0157	0.0408	CbGbCtD
Mebendazole—ABCB1—Phenytoin—epilepsy syndrome	0.0148	0.0383	CbGbCtD
Mebendazole—CYP3A4—Felbamate—epilepsy syndrome	0.0146	0.0379	CbGbCtD
Mebendazole—CYP3A4—Trimethadione—epilepsy syndrome	0.0146	0.0379	CbGbCtD
Mebendazole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0137	0.0356	CbGbCtD
Mebendazole—ABCB1—Phenobarbital—epilepsy syndrome	0.0132	0.0342	CbGbCtD
Mebendazole—ABCB1—Midazolam—epilepsy syndrome	0.013	0.0337	CbGbCtD
Mebendazole—ABCB1—Diazepam—epilepsy syndrome	0.0125	0.0324	CbGbCtD
Mebendazole—CYP3A4—Clonazepam—epilepsy syndrome	0.0124	0.0322	CbGbCtD
Mebendazole—CYP3A4—Clobazam—epilepsy syndrome	0.0119	0.0309	CbGbCtD
Mebendazole—CYP3A4—Rufinamide—epilepsy syndrome	0.0101	0.0263	CbGbCtD
Mebendazole—CYP3A4—Carbamazepine—epilepsy syndrome	0.00987	0.0256	CbGbCtD
Mebendazole—CYP3A4—Primidone—epilepsy syndrome	0.00921	0.0239	CbGbCtD
Mebendazole—CYP3A4—Phenytoin—epilepsy syndrome	0.00885	0.023	CbGbCtD
Mebendazole—CYP3A4—Propofol—epilepsy syndrome	0.00826	0.0214	CbGbCtD
Mebendazole—CYP3A4—Phenobarbital—epilepsy syndrome	0.00789	0.0205	CbGbCtD
Mebendazole—CYP3A4—Acetazolamide—epilepsy syndrome	0.00789	0.0205	CbGbCtD
Mebendazole—CYP3A4—Midazolam—epilepsy syndrome	0.00778	0.0202	CbGbCtD
Mebendazole—CYP3A4—Diazepam—epilepsy syndrome	0.00748	0.0194	CbGbCtD
Mebendazole—CYP3A4—Zonisamide—epilepsy syndrome	0.0073	0.0189	CbGbCtD
Mebendazole—TUBA1A—pons—epilepsy syndrome	0.00661	0.202	CbGeAlD
Mebendazole—CYP3A4—Valproic Acid—epilepsy syndrome	0.0059	0.0153	CbGbCtD
Mebendazole—CYP3A4—Topiramate—epilepsy syndrome	0.00532	0.0138	CbGbCtD
Mebendazole—Prolonged menses—Clonazepam—epilepsy syndrome	0.00526	0.0622	CcSEcCtD
Mebendazole—TUBA1A—ganglion—epilepsy syndrome	0.00339	0.103	CbGeAlD
Mebendazole—TUBA1A—hindbrain—epilepsy syndrome	0.00257	0.0784	CbGeAlD
Mebendazole—Menorrhagia—Zonisamide—epilepsy syndrome	0.00155	0.0183	CcSEcCtD
Mebendazole—Menorrhagia—Clonazepam—epilepsy syndrome	0.00149	0.0176	CcSEcCtD
Mebendazole—TUBA1A—brainstem—epilepsy syndrome	0.00147	0.0449	CbGeAlD
Mebendazole—Menorrhagia—Oxcarbazepine—epilepsy syndrome	0.00147	0.0174	CcSEcCtD
Mebendazole—TUBA1A—forebrain—epilepsy syndrome	0.00142	0.0434	CbGeAlD
Mebendazole—Menorrhagia—Lamotrigine—epilepsy syndrome	0.00137	0.0161	CcSEcCtD
Mebendazole—TUBB4B—Niclosamide—Clonazepam—epilepsy syndrome	0.00136	1	CbGdCrCtD
Mebendazole—TUBA1A—telencephalon—epilepsy syndrome	0.00131	0.0399	CbGeAlD
Mebendazole—Agranulocytosis—Primidone—epilepsy syndrome	0.00122	0.0144	CcSEcCtD
Mebendazole—Neutropenia—Trimethadione—epilepsy syndrome	0.00121	0.0143	CcSEcCtD
Mebendazole—Agranulocytosis—Trimethadione—epilepsy syndrome	0.00107	0.0127	CcSEcCtD
Mebendazole—Neutropenia—Rufinamide—epilepsy syndrome	0.00105	0.0124	CcSEcCtD
Mebendazole—Hepatitis—Trimethadione—epilepsy syndrome	0.00103	0.0122	CcSEcCtD
Mebendazole—TUBA1A—medulla oblongata—epilepsy syndrome	0.00103	0.0313	CbGeAlD
Mebendazole—Neutropenia—Lacosamide—epilepsy syndrome	0.000985	0.0116	CcSEcCtD
Mebendazole—Menorrhagia—Pregabalin—epilepsy syndrome	0.000981	0.0116	CcSEcCtD
Mebendazole—Angioedema—Amobarbital—epilepsy syndrome	0.00097	0.0115	CcSEcCtD
Mebendazole—TUBB4B—forebrain—epilepsy syndrome	0.000947	0.0289	CbGeAlD
Mebendazole—TUBA1A—midbrain—epilepsy syndrome	0.000938	0.0286	CbGeAlD
Mebendazole—TUBA1A—spinal cord—epilepsy syndrome	0.000916	0.0279	CbGeAlD
Mebendazole—Hepatitis—Phenobarbital—epilepsy syndrome	0.000915	0.0108	CcSEcCtD
Mebendazole—Menorrhagia—Gabapentin—epilepsy syndrome	0.000899	0.0106	CcSEcCtD
Mebendazole—Agranulocytosis—Lacosamide—epilepsy syndrome	0.000877	0.0104	CcSEcCtD
Mebendazole—TUBB4B—telencephalon—epilepsy syndrome	0.000871	0.0266	CbGeAlD
Mebendazole—Hepatitis—Lacosamide—epilepsy syndrome	0.000843	0.00997	CcSEcCtD
Mebendazole—TUBA1A—head—epilepsy syndrome	0.000814	0.0248	CbGeAlD
Mebendazole—TUBA1A—nervous system—epilepsy syndrome	0.000772	0.0235	CbGeAlD
Mebendazole—Neutropenia—Levetiracetam—epilepsy syndrome	0.000765	0.00904	CcSEcCtD
Mebendazole—Agranulocytosis—Acetazolamide—epilepsy syndrome	0.000758	0.00896	CcSEcCtD
Mebendazole—Menorrhagia—Topiramate—epilepsy syndrome	0.000757	0.00894	CcSEcCtD
Mebendazole—TUBA1A—central nervous system—epilepsy syndrome	0.000743	0.0227	CbGeAlD
Mebendazole—Angioedema—Phenobarbital—epilepsy syndrome	0.000728	0.0086	CcSEcCtD
Mebendazole—TUBA1A—cerebellum—epilepsy syndrome	0.000726	0.0222	CbGeAlD
Mebendazole—Neutropenia—Diazepam—epilepsy syndrome	0.000708	0.00837	CcSEcCtD
Mebendazole—TUBB4B—medulla oblongata—epilepsy syndrome	0.000684	0.0209	CbGeAlD
Mebendazole—Agranulocytosis—Levetiracetam—epilepsy syndrome	0.000681	0.00804	CcSEcCtD
Mebendazole—Convulsion—Rufinamide—epilepsy syndrome	0.000678	0.00801	CcSEcCtD
Mebendazole—Angioedema—Lacosamide—epilepsy syndrome	0.000671	0.00793	CcSEcCtD
Mebendazole—Hepatitis—Levetiracetam—epilepsy syndrome	0.000655	0.00774	CcSEcCtD
Mebendazole—Neutropenia—Oxcarbazepine—epilepsy syndrome	0.000639	0.00755	CcSEcCtD
Mebendazole—Hypersensitivity—Amobarbital—epilepsy syndrome	0.000638	0.00754	CcSEcCtD
Mebendazole—Agranulocytosis—Diazepam—epilepsy syndrome	0.00063	0.00745	CcSEcCtD
Mebendazole—TUBB4B—midbrain—epilepsy syndrome	0.000626	0.0191	CbGeAlD
Mebendazole—TUBB4B—spinal cord—epilepsy syndrome	0.00061	0.0186	CbGeAlD
Mebendazole—Agranulocytosis—Felbamate—epilepsy syndrome	0.00061	0.00721	CcSEcCtD
Mebendazole—Gastrointestinal pain—Trimethadione—epilepsy syndrome	0.0006	0.0071	CcSEcCtD
Mebendazole—Agranulocytosis—Zonisamide—epilepsy syndrome	0.000597	0.00706	CcSEcCtD
Mebendazole—Neutropenia—Lamotrigine—epilepsy syndrome	0.000593	0.00701	CcSEcCtD
Mebendazole—TUBA1A—brain—epilepsy syndrome	0.00059	0.018	CbGeAlD
Mebendazole—Hepatitis—Felbamate—epilepsy syndrome	0.000587	0.00694	CcSEcCtD
Mebendazole—Abdominal pain—Trimethadione—epilepsy syndrome	0.00058	0.00686	CcSEcCtD
Mebendazole—Agranulocytosis—Phenytoin—epilepsy syndrome	0.000572	0.00676	CcSEcCtD
Mebendazole—Agranulocytosis—Oxcarbazepine—epilepsy syndrome	0.000569	0.00672	CcSEcCtD
Mebendazole—Convulsion—Acetazolamide—epilepsy syndrome	0.00055	0.0065	CcSEcCtD
Mebendazole—Hepatitis—Oxcarbazepine—epilepsy syndrome	0.000547	0.00647	CcSEcCtD
Mebendazole—Rash—Amobarbital—epilepsy syndrome	0.000546	0.00646	CcSEcCtD
Mebendazole—Agranulocytosis—Carbamazepine—epilepsy syndrome	0.000546	0.00645	CcSEcCtD
Mebendazole—Dermatitis—Amobarbital—epilepsy syndrome	0.000546	0.00645	CcSEcCtD
Mebendazole—TUBB4B—head—epilepsy syndrome	0.000542	0.0166	CbGeAlD
Mebendazole—Angioedema—Propofol—epilepsy syndrome	0.000539	0.00637	CcSEcCtD
Mebendazole—Agranulocytosis—Lamotrigine—epilepsy syndrome	0.000527	0.00623	CcSEcCtD
Mebendazole—Rash—Primidone—epilepsy syndrome	0.000526	0.00622	CcSEcCtD
Mebendazole—Dermatitis—Primidone—epilepsy syndrome	0.000526	0.00621	CcSEcCtD
Mebendazole—Hepatitis—Carbamazepine—epilepsy syndrome	0.000525	0.0062	CcSEcCtD
Mebendazole—Urticaria—Phenobarbital—epilepsy syndrome	0.000517	0.0061	CcSEcCtD
Mebendazole—TUBB4B—nervous system—epilepsy syndrome	0.000514	0.0157	CbGeAlD
Mebendazole—Convulsion—Propofol—epilepsy syndrome	0.000511	0.00604	CcSEcCtD
Mebendazole—Hepatitis—Lamotrigine—epilepsy syndrome	0.000507	0.006	CcSEcCtD
Mebendazole—TUBB4B—central nervous system—epilepsy syndrome	0.000495	0.0151	CbGeAlD
Mebendazole—Convulsion—Levetiracetam—epilepsy syndrome	0.000494	0.00584	CcSEcCtD
Mebendazole—Angioedema—Vigabatrin—epilepsy syndrome	0.00049	0.00579	CcSEcCtD
Mebendazole—TUBB4B—cerebellum—epilepsy syndrome	0.000484	0.0148	CbGeAlD
Mebendazole—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000479	0.00566	CcSEcCtD
Mebendazole—Convulsion—Fosphenytoin—epilepsy syndrome	0.000477	0.00563	CcSEcCtD
Mebendazole—Urticaria—Lacosamide—epilepsy syndrome	0.000476	0.00563	CcSEcCtD
Mebendazole—Neutropenia—Valproic Acid—epilepsy syndrome	0.000471	0.00557	CcSEcCtD
Mebendazole—Hypersensitivity—Rufinamide—epilepsy syndrome	0.00047	0.00556	CcSEcCtD
Mebendazole—Convulsion—Vigabatrin—epilepsy syndrome	0.000465	0.00549	CcSEcCtD
Mebendazole—Rash—Trimethadione—epilepsy syndrome	0.000463	0.00547	CcSEcCtD
Mebendazole—Dermatitis—Trimethadione—epilepsy syndrome	0.000462	0.00547	CcSEcCtD
Mebendazole—Urticaria—Clobazam—epilepsy syndrome	0.000462	0.00546	CcSEcCtD
Mebendazole—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000442	0.00522	CcSEcCtD
Mebendazole—Angioedema—Clonazepam—epilepsy syndrome	0.00044	0.00521	CcSEcCtD
Mebendazole—Angioedema—Oxcarbazepine—epilepsy syndrome	0.000435	0.00514	CcSEcCtD
Mebendazole—Ketoprofen—SLCO1A2—epilepsy syndrome	0.000433	0.252	CrCbGaD
Mebendazole—Convulsion—Zonisamide—epilepsy syndrome	0.000433	0.00512	CcSEcCtD
Mebendazole—Neutropenia—Pregabalin—epilepsy syndrome	0.000426	0.00503	CcSEcCtD
Mebendazole—Agranulocytosis—Valproic Acid—epilepsy syndrome	0.000419	0.00495	CcSEcCtD
Mebendazole—Angioedema—Carbamazepine—epilepsy syndrome	0.000418	0.00494	CcSEcCtD
Mebendazole—Convulsion—Phenytoin—epilepsy syndrome	0.000415	0.0049	CcSEcCtD
Mebendazole—Convulsion—Oxcarbazepine—epilepsy syndrome	0.000413	0.00488	CcSEcCtD
Mebendazole—Urticaria—Acetazolamide—epilepsy syndrome	0.000412	0.00487	CcSEcCtD
Mebendazole—Rash—Phenobarbital—epilepsy syndrome	0.00041	0.00485	CcSEcCtD
Mebendazole—Dermatitis—Phenobarbital—epilepsy syndrome	0.00041	0.00484	CcSEcCtD
Mebendazole—Angioedema—Lamotrigine—epilepsy syndrome	0.000404	0.00477	CcSEcCtD
Mebendazole—Rash—Rufinamide—epilepsy syndrome	0.000402	0.00476	CcSEcCtD
Mebendazole—Dermatitis—Rufinamide—epilepsy syndrome	0.000402	0.00475	CcSEcCtD
Mebendazole—Convulsion—Carbamazepine—epilepsy syndrome	0.000396	0.00468	CcSEcCtD
Mebendazole—TUBB4B—brain—epilepsy syndrome	0.000393	0.012	CbGeAlD
Mebendazole—Convulsion—Lamotrigine—epilepsy syndrome	0.000383	0.00452	CcSEcCtD
Mebendazole—Urticaria—Propofol—epilepsy syndrome	0.000383	0.00452	CcSEcCtD
Mebendazole—Abdominal pain—Propofol—epilepsy syndrome	0.000381	0.0045	CcSEcCtD
Mebendazole—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.00038	0.0045	CcSEcCtD
Mebendazole—Rash—Lacosamide—epilepsy syndrome	0.000378	0.00447	CcSEcCtD
Mebendazole—Dermatitis—Lacosamide—epilepsy syndrome	0.000377	0.00446	CcSEcCtD
Mebendazole—Albendazole—ABCB1—epilepsy syndrome	0.000377	0.219	CrCbGaD
Mebendazole—Urticaria—Midazolam—epilepsy syndrome	0.000374	0.00442	CcSEcCtD
Mebendazole—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000368	0.00435	CcSEcCtD
Mebendazole—Rash—Clobazam—epilepsy syndrome	0.000367	0.00433	CcSEcCtD
Mebendazole—Dermatitis—Clobazam—epilepsy syndrome	0.000366	0.00433	CcSEcCtD
Mebendazole—Hepatitis—Pregabalin—epilepsy syndrome	0.000365	0.00431	CcSEcCtD
Mebendazole—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000358	0.00423	CcSEcCtD
Mebendazole—Urticaria—Fosphenytoin—epilepsy syndrome	0.000357	0.00422	CcSEcCtD
Mebendazole—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000352	0.00416	CcSEcCtD
Mebendazole—Urticaria—Vigabatrin—epilepsy syndrome	0.000348	0.00411	CcSEcCtD
Mebendazole—Hypersensitivity—Midazolam—epilepsy syndrome	0.000347	0.0041	CcSEcCtD
Mebendazole—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000346	0.00409	CcSEcCtD
Mebendazole—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000343	0.00405	CcSEcCtD
Mebendazole—Urticaria—Diazepam—epilepsy syndrome	0.000342	0.00405	CcSEcCtD
Mebendazole—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000341	0.00403	CcSEcCtD
Mebendazole—Abdominal pain—Diazepam—epilepsy syndrome	0.000341	0.00403	CcSEcCtD
Mebendazole—Hepatitis—Gabapentin—epilepsy syndrome	0.000334	0.00395	CcSEcCtD
Mebendazole—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000334	0.00394	CcSEcCtD
Mebendazole—Urticaria—Felbamate—epilepsy syndrome	0.000331	0.00392	CcSEcCtD
Mebendazole—Abdominal pain—Felbamate—epilepsy syndrome	0.00033	0.0039	CcSEcCtD
Mebendazole—Neutropenia—Topiramate—epilepsy syndrome	0.000329	0.00388	CcSEcCtD
Mebendazole—Urticaria—Zonisamide—epilepsy syndrome	0.000324	0.00383	CcSEcCtD
Mebendazole—Abdominal pain—Zonisamide—epilepsy syndrome	0.000323	0.00381	CcSEcCtD
Mebendazole—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000322	0.00381	CcSEcCtD
Mebendazole—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000322	0.0038	CcSEcCtD
Mebendazole—Angioedema—Valproic Acid—epilepsy syndrome	0.000321	0.00379	CcSEcCtD
Mebendazole—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000318	0.00376	CcSEcCtD
Mebendazole—Hypersensitivity—Diazepam—epilepsy syndrome	0.000317	0.00375	CcSEcCtD
Mebendazole—Urticaria—Clonazepam—epilepsy syndrome	0.000313	0.00369	CcSEcCtD
Mebendazole—Abdominal pain—Clonazepam—epilepsy syndrome	0.000311	0.00368	CcSEcCtD
Mebendazole—Urticaria—Phenytoin—epilepsy syndrome	0.00031	0.00367	CcSEcCtD
Mebendazole—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000309	0.00365	CcSEcCtD
Mebendazole—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000307	0.00363	CcSEcCtD
Mebendazole—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000305	0.0036	CcSEcCtD
Mebendazole—CYP1A1—head—epilepsy syndrome	0.000304	0.00927	CbGeAlD
Mebendazole—Rash—Propofol—epilepsy syndrome	0.000304	0.00359	CcSEcCtD
Mebendazole—Dermatitis—Propofol—epilepsy syndrome	0.000303	0.00358	CcSEcCtD
Mebendazole—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000301	0.00355	CcSEcCtD
Mebendazole—Rash—Midazolam—epilepsy syndrome	0.000297	0.00351	CcSEcCtD
Mebendazole—Dermatitis—Midazolam—epilepsy syndrome	0.000297	0.00351	CcSEcCtD
Mebendazole—Urticaria—Carbamazepine—epilepsy syndrome	0.000296	0.0035	CcSEcCtD
Mebendazole—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000295	0.00348	CcSEcCtD
Mebendazole—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000295	0.00348	CcSEcCtD
Mebendazole—Rash—Levetiracetam—epilepsy syndrome	0.000293	0.00347	CcSEcCtD
Mebendazole—Dermatitis—Levetiracetam—epilepsy syndrome	0.000293	0.00346	CcSEcCtD
Mebendazole—Agranulocytosis—Topiramate—epilepsy syndrome	0.000292	0.00345	CcSEcCtD
Mebendazole—Angioedema—Pregabalin—epilepsy syndrome	0.00029	0.00343	CcSEcCtD
Mebendazole—Hypersensitivity—Clonazepam—epilepsy syndrome	0.00029	0.00343	CcSEcCtD
Mebendazole—CYP1A1—nervous system—epilepsy syndrome	0.000288	0.00879	CbGeAlD
Mebendazole—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000288	0.0034	CcSEcCtD
Mebendazole—Urticaria—Lamotrigine—epilepsy syndrome	0.000286	0.00338	CcSEcCtD
Mebendazole—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000286	0.00338	CcSEcCtD
Mebendazole—Ketorolac—PTGS2—epilepsy syndrome	0.000285	0.166	CrCbGaD
Mebendazole—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000285	0.00337	CcSEcCtD
Mebendazole—Rash—Fosphenytoin—epilepsy syndrome	0.000283	0.00335	CcSEcCtD
Mebendazole—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000283	0.00334	CcSEcCtD
Mebendazole—Hepatitis—Topiramate—epilepsy syndrome	0.000281	0.00332	CcSEcCtD
Mebendazole—CYP1A1—central nervous system—epilepsy syndrome	0.000277	0.00846	CbGeAlD
Mebendazole—Rash—Vigabatrin—epilepsy syndrome	0.000276	0.00326	CcSEcCtD
Mebendazole—Dermatitis—Vigabatrin—epilepsy syndrome	0.000276	0.00326	CcSEcCtD
Mebendazole—ABCB1—forebrain—epilepsy syndrome	0.000275	0.00841	CbGeAlD
Mebendazole—Convulsion—Pregabalin—epilepsy syndrome	0.000275	0.00325	CcSEcCtD
Mebendazole—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000275	0.00325	CcSEcCtD
Mebendazole—Rash—Diazepam—epilepsy syndrome	0.000272	0.00321	CcSEcCtD
Mebendazole—Dermatitis—Diazepam—epilepsy syndrome	0.000271	0.00321	CcSEcCtD
Mebendazole—Angioedema—Gabapentin—epilepsy syndrome	0.000266	0.00314	CcSEcCtD
Mebendazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000266	0.00314	CcSEcCtD
Mebendazole—Rash—Felbamate—epilepsy syndrome	0.000263	0.00311	CcSEcCtD
Mebendazole—Dermatitis—Felbamate—epilepsy syndrome	0.000263	0.0031	CcSEcCtD
Mebendazole—Rash—Zonisamide—epilepsy syndrome	0.000257	0.00304	CcSEcCtD
Mebendazole—Dermatitis—Zonisamide—epilepsy syndrome	0.000257	0.00304	CcSEcCtD
Mebendazole—ABCB1—telencephalon—epilepsy syndrome	0.000253	0.00773	CbGeAlD
Mebendazole—Convulsion—Gabapentin—epilepsy syndrome	0.000252	0.00298	CcSEcCtD
Mebendazole—Rash—Clonazepam—epilepsy syndrome	0.000248	0.00293	CcSEcCtD
Mebendazole—Dermatitis—Clonazepam—epilepsy syndrome	0.000248	0.00293	CcSEcCtD
Mebendazole—Rash—Phenytoin—epilepsy syndrome	0.000246	0.00291	CcSEcCtD
Mebendazole—Dermatitis—Phenytoin—epilepsy syndrome	0.000246	0.00291	CcSEcCtD
Mebendazole—Rash—Oxcarbazepine—epilepsy syndrome	0.000245	0.0029	CcSEcCtD
Mebendazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000245	0.00289	CcSEcCtD
Mebendazole—Rash—Carbamazepine—epilepsy syndrome	0.000235	0.00278	CcSEcCtD
Mebendazole—Dermatitis—Carbamazepine—epilepsy syndrome	0.000235	0.00278	CcSEcCtD
Mebendazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000234	0.00277	CcSEcCtD
Mebendazole—Tiaprofenic acid—PTGS2—epilepsy syndrome	0.000233	0.135	CrCbGaD
Mebendazole—Urticaria—Valproic Acid—epilepsy syndrome	0.000228	0.00269	CcSEcCtD
Mebendazole—Rash—Lamotrigine—epilepsy syndrome	0.000227	0.00269	CcSEcCtD
Mebendazole—Dermatitis—Lamotrigine—epilepsy syndrome	0.000227	0.00268	CcSEcCtD
Mebendazole—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000226	0.00268	CcSEcCtD
Mebendazole—Nepafenac—PTGS2—epilepsy syndrome	0.000221	0.129	CrCbGaD
Mebendazole—CYP1A1—brain—epilepsy syndrome	0.00022	0.00672	CbGeAlD
Mebendazole—Convulsion—Topiramate—epilepsy syndrome	0.000212	0.00251	CcSEcCtD
Mebendazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000212	0.0025	CcSEcCtD
Mebendazole—CYP3A4—nervous system—epilepsy syndrome	0.000211	0.00645	CbGeAlD
Mebendazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000211	0.00249	CcSEcCtD
Mebendazole—Urticaria—Pregabalin—epilepsy syndrome	0.000206	0.00243	CcSEcCtD
Mebendazole—Abdominal pain—Pregabalin—epilepsy syndrome	0.000205	0.00242	CcSEcCtD
Mebendazole—CYP3A4—central nervous system—epilepsy syndrome	0.000203	0.00621	CbGeAlD
Mebendazole—ABCB1—medulla oblongata—epilepsy syndrome	0.000199	0.00608	CbGeAlD
Mebendazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000194	0.0023	CcSEcCtD
Mebendazole—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000191	0.00225	CcSEcCtD
Mebendazole—Urticaria—Gabapentin—epilepsy syndrome	0.000189	0.00223	CcSEcCtD
Mebendazole—Abdominal pain—Gabapentin—epilepsy syndrome	0.000188	0.00222	CcSEcCtD
Mebendazole—ABCB1—midbrain—epilepsy syndrome	0.000182	0.00555	CbGeAlD
Mebendazole—Rash—Valproic Acid—epilepsy syndrome	0.000181	0.00213	CcSEcCtD
Mebendazole—Dermatitis—Valproic Acid—epilepsy syndrome	0.00018	0.00213	CcSEcCtD
Mebendazole—ABCB1—spinal cord—epilepsy syndrome	0.000177	0.00542	CbGeAlD
Mebendazole—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000175	0.00207	CcSEcCtD
Mebendazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000163	0.00193	CcSEcCtD
Mebendazole—Rash—Pregabalin—epilepsy syndrome	0.000163	0.00193	CcSEcCtD
Mebendazole—Dermatitis—Pregabalin—epilepsy syndrome	0.000163	0.00193	CcSEcCtD
Mebendazole—Urticaria—Topiramate—epilepsy syndrome	0.000159	0.00188	CcSEcCtD
Mebendazole—Abdominal pain—Topiramate—epilepsy syndrome	0.000158	0.00187	CcSEcCtD
Mebendazole—ABCB1—head—epilepsy syndrome	0.000158	0.00481	CbGeAlD
Mebendazole—Rash—Gabapentin—epilepsy syndrome	0.00015	0.00177	CcSEcCtD
Mebendazole—Dermatitis—Gabapentin—epilepsy syndrome	0.00015	0.00177	CcSEcCtD
Mebendazole—ABCB1—nervous system—epilepsy syndrome	0.00015	0.00456	CbGeAlD
Mebendazole—Hypersensitivity—Topiramate—epilepsy syndrome	0.000147	0.00174	CcSEcCtD
Mebendazole—ABCB1—central nervous system—epilepsy syndrome	0.000144	0.00439	CbGeAlD
Mebendazole—ABCB1—cerebellum—epilepsy syndrome	0.000141	0.0043	CbGeAlD
Mebendazole—Rash—Topiramate—epilepsy syndrome	0.000126	0.00149	CcSEcCtD
Mebendazole—Dermatitis—Topiramate—epilepsy syndrome	0.000126	0.00149	CcSEcCtD
Mebendazole—ABCB1—brain—epilepsy syndrome	0.000114	0.00349	CbGeAlD
Mebendazole—Ketoprofen—PTGS2—epilepsy syndrome	8.97e-05	0.0522	CrCbGaD
Mebendazole—Ketoprofen—ALB—epilepsy syndrome	7.99e-05	0.0465	CrCbGaD
Mebendazole—TUBA1A—Metabolism of proteins—POMC—epilepsy syndrome	3.08e-05	0.000665	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.08e-05	0.000665	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—H2AFX—epilepsy syndrome	3.08e-05	0.000664	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CCL2—epilepsy syndrome	3.01e-05	0.000651	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.98e-05	0.000644	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	2.87e-05	0.00062	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	2.74e-05	0.000592	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.67e-05	0.000577	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CA13—epilepsy syndrome	2.65e-05	0.000573	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—JUN—epilepsy syndrome	2.64e-05	0.000569	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	2.53e-05	0.000546	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PDXK—epilepsy syndrome	2.52e-05	0.000543	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—L2HGDH—epilepsy syndrome	2.52e-05	0.000543	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—FAR1—epilepsy syndrome	2.52e-05	0.000543	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CERS1—epilepsy syndrome	2.52e-05	0.000543	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GLUD1—epilepsy syndrome	2.52e-05	0.000543	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ADK—epilepsy syndrome	2.52e-05	0.000543	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—ATM—epilepsy syndrome	2.5e-05	0.00054	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	2.46e-05	0.000532	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	2.46e-05	0.000532	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PRKCB—epilepsy syndrome	2.45e-05	0.000529	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—epilepsy syndrome	2.44e-05	0.000528	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.44e-05	0.000526	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.39e-05	0.000516	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2.37e-05	0.000513	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	2.35e-05	0.000509	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.35e-05	0.000509	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	2.35e-05	0.000508	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	2.35e-05	0.000507	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.34e-05	0.000505	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	2.32e-05	0.000501	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	2.31e-05	0.000499	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	2.3e-05	0.000497	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—EPM2A—epilepsy syndrome	2.3e-05	0.000497	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PNPO—epilepsy syndrome	2.3e-05	0.000497	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NHLRC1—epilepsy syndrome	2.3e-05	0.000497	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GAMT—epilepsy syndrome	2.3e-05	0.000497	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.25e-05	0.000487	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.25e-05	0.000487	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.25e-05	0.000487	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.25e-05	0.000487	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—AGT—epilepsy syndrome	2.21e-05	0.000477	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.14e-05	0.000463	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—QDPR—epilepsy syndrome	2.14e-05	0.000462	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CA4—epilepsy syndrome	2.14e-05	0.000462	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—POMC—epilepsy syndrome	2.13e-05	0.000461	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.11e-05	0.000456	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.09e-05	0.000452	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—COX3—epilepsy syndrome	2.01e-05	0.000434	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.01e-05	0.000434	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.01e-05	0.000434	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ADK—epilepsy syndrome	2.01e-05	0.000434	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.01e-05	0.000434	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.01e-05	0.000434	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.01e-05	0.000434	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2e-05	0.000432	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	1.99e-05	0.000431	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.98e-05	0.000427	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.97e-05	0.000425	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.92e-05	0.000414	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLCO1A2—epilepsy syndrome	1.91e-05	0.000412	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PFKL—epilepsy syndrome	1.91e-05	0.000412	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—KCNB1—epilepsy syndrome	1.91e-05	0.000412	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CACNA2D2—epilepsy syndrome	1.91e-05	0.000412	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC6A8—epilepsy syndrome	1.91e-05	0.000412	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.87e-05	0.000403	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.86e-05	0.000402	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—POMC—epilepsy syndrome	1.86e-05	0.000402	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.85e-05	0.0004	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.84e-05	0.000398	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PNPO—epilepsy syndrome	1.84e-05	0.000397	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GAMT—epilepsy syndrome	1.84e-05	0.000397	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	1.84e-05	0.000397	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—EPM2A—epilepsy syndrome	1.84e-05	0.000397	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CCL2—epilepsy syndrome	1.82e-05	0.000393	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.78e-05	0.000385	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.78e-05	0.000385	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	1.76e-05	0.000379	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ATIC—epilepsy syndrome	1.74e-05	0.000377	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NEU1—epilepsy syndrome	1.74e-05	0.000377	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—UPB1—epilepsy syndrome	1.74e-05	0.000377	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.71e-05	0.000369	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.71e-05	0.000369	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CA4—epilepsy syndrome	1.71e-05	0.000369	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.71e-05	0.000369	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HSD17B4—epilepsy syndrome	1.68e-05	0.000362	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.63e-05	0.000353	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GBE1—epilepsy syndrome	1.62e-05	0.00035	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPP1R3C—epilepsy syndrome	1.62e-05	0.00035	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—COX3—epilepsy syndrome	1.61e-05	0.000347	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.59e-05	0.000343	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.58e-05	0.000342	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.53e-05	0.000331	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ASAH1—epilepsy syndrome	1.52e-05	0.000329	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.52e-05	0.000329	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.52e-05	0.000329	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.52e-05	0.000329	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.52e-05	0.000329	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.52e-05	0.000329	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—STXBP1—epilepsy syndrome	1.48e-05	0.00032	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.47e-05	0.000317	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.45e-05	0.000314	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NT5E—epilepsy syndrome	1.44e-05	0.000312	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALAD—epilepsy syndrome	1.44e-05	0.000312	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.42e-05	0.000306	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.39e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.39e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.39e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.38e-05	0.000299	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CACNA1A—epilepsy syndrome	1.38e-05	0.000298	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALDH7A1—epilepsy syndrome	1.38e-05	0.000298	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ST3GAL3—epilepsy syndrome	1.35e-05	0.000291	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.34e-05	0.00029	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ADSL—epilepsy syndrome	1.32e-05	0.000285	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.31e-05	0.000284	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GLUL—epilepsy syndrome	1.3e-05	0.00028	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.29e-05	0.00028	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.29e-05	0.00028	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CACNA1D—epilepsy syndrome	1.27e-05	0.000275	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.25e-05	0.00027	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.24e-05	0.000267	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.24e-05	0.000267	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.24e-05	0.000267	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.24e-05	0.000267	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.24e-05	0.000267	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.24e-05	0.000267	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.22e-05	0.000263	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.2e-05	0.00026	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TXNRD1—epilepsy syndrome	1.19e-05	0.000257	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.18e-05	0.000256	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.16e-05	0.00025	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AQP1—epilepsy syndrome	1.15e-05	0.000249	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.15e-05	0.000249	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.15e-05	0.000249	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.15e-05	0.000248	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.13e-05	0.000245	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.13e-05	0.000245	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.13e-05	0.000245	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.13e-05	0.000245	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.13e-05	0.000243	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.11e-05	0.00024	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.1e-05	0.000238	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.1e-05	0.000238	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.08e-05	0.000233	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.06e-05	0.000228	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.05e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.05e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.05e-05	0.000227	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	1.04e-05	0.000226	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	1.04e-05	0.000226	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.03e-05	0.000224	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.02e-05	0.000219	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.01e-05	0.000218	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—COX3—epilepsy syndrome	9.9e-06	0.000214	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	9.84e-06	0.000213	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.73e-06	0.00021	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.53e-06	0.000206	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	9.5e-06	0.000205	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	9.44e-06	0.000204	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PFKL—epilepsy syndrome	9.38e-06	0.000203	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	9.38e-06	0.000203	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	9.38e-06	0.000203	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	9.38e-06	0.000203	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	9.38e-06	0.000203	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	9.36e-06	0.000202	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AQP1—epilepsy syndrome	9.22e-06	0.000199	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	8.58e-06	0.000185	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	8.58e-06	0.000185	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	8.58e-06	0.000185	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	8.51e-06	0.000184	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	8.43e-06	0.000182	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	8.34e-06	0.00018	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CHRM3—epilepsy syndrome	8.34e-06	0.00018	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	8.3e-06	0.000179	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	8.26e-06	0.000178	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	8.25e-06	0.000178	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.19e-06	0.000177	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	7.98e-06	0.000172	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	7.98e-06	0.000172	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	7.5e-06	0.000162	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.46e-06	0.000161	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	7.44e-06	0.000161	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.3e-06	0.000158	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.11e-06	0.000154	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.11e-06	0.000154	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	7.08e-06	0.000153	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—BCHE—epilepsy syndrome	7.06e-06	0.000152	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ABCG2—epilepsy syndrome	6.8e-06	0.000147	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	6.78e-06	0.000146	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	6.78e-06	0.000146	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	6.73e-06	0.000145	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	6.66e-06	0.000144	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.64e-06	0.000143	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TH—epilepsy syndrome	6.63e-06	0.000143	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	6.63e-06	0.000143	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	6.59e-06	0.000142	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.53e-06	0.000141	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	6.5e-06	0.00014	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.38e-06	0.000138	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.28e-06	0.000136	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.26e-06	0.000135	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	5.94e-06	0.000128	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.85e-06	0.000126	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.68e-06	0.000123	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.67e-06	0.000122	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	5.66e-06	0.000122	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—BCHE—epilepsy syndrome	5.64e-06	0.000122	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	5.54e-06	0.00012	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CAT—epilepsy syndrome	5.46e-06	0.000118	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.38e-06	0.000116	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.32e-06	0.000115	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	5.31e-06	0.000115	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TH—epilepsy syndrome	5.3e-06	0.000114	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.14e-06	0.000111	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.14e-06	0.000111	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GPX1—epilepsy syndrome	4.94e-06	0.000107	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.42e-06	9.55e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CAT—epilepsy syndrome	4.36e-06	9.42e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AGT—epilepsy syndrome	4.33e-06	9.36e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—APOE—epilepsy syndrome	4.24e-06	9.17e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.19e-06	9.05e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.08e-06	8.82e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.06e-06	8.76e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.95e-06	8.52e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.66e-06	7.91e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—POMC—epilepsy syndrome	3.65e-06	7.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.49e-06	7.53e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.47e-06	7.5e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AGT—epilepsy syndrome	3.46e-06	7.47e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—APOE—epilepsy syndrome	3.39e-06	7.32e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALB—epilepsy syndrome	3.32e-06	7.18e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.31e-06	7.15e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.28e-06	7.08e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TH—epilepsy syndrome	3.26e-06	7.05e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—POMC—epilepsy syndrome	2.91e-06	6.29e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	2.91e-06	6.28e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.72e-06	5.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.69e-06	5.81e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALB—epilepsy syndrome	2.66e-06	5.73e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.61e-06	5.65e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.43e-06	5.25e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.32e-06	5.02e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.13e-06	4.6e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.09e-06	4.51e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.79e-06	3.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.64e-06	3.53e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—epilepsy syndrome	1.46e-06	3.16e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.43e-06	3.09e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.17e-06	2.52e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.19e-07	1.55e-05	CbGpPWpGaD
